"We aim to develop better therapies for brain cancers by combining existing cytotoxic drugs with our novel drugs that directly trigger cell death. Our drugs have shown efficacy in clinical trials for leukaemia. We will now test whether they can cross into the brain and be efficacious in brain cancer."

- Prof Andreas Strasser, researcher at Cure Brain Cancer